Position in REGN
as of Sep 30, 2025
· filed Nov 4, 2025
Position Value
$5,060
New position
Shares Held
9
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Sep 30, 2025Guerra Advisors Inc holds $27,600 across 14 Biotechnology names. REGN ranks #2 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15 | $6,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
9 | $5,060 | |
| 3 | RXRX |
Recursion Pharmaceuticals, Inc.
|
1,000 | $4,880 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9 | $3,524 | |
| 5 | TECH |
BIO-TECHNE Corp
|
45 | $2,503 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
45 | $1,552 | |
| 7 | MRNA |
Moderna, Inc.
|
42 | $1,084 | |
| 8 | INCY |
Incyte Corp
|
10 | $848 |
All Filings in REGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-09-30 | $5,060 | 9 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||